Literature DB >> 11309287

An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study.

H Shen1, E M Sturgis, S G Khan, Y Qiao, T Shahlavi, S A Eicher, Y Xu, X Wang, S S Strom, M R Spitz, K H Kraemer, Q Wei.   

Abstract

Inherited polymorphisms of DNA repair genes may contribute to variations in DNA repair capacity and genetic susceptibility to cancer. In a hospital-based case-control study of 287 non-Hispanic white patients with newly diagnosed SCCHN and 311 control subjects matched on age, sex, ethnicity, and smoking status, we investigated the role of a newly identified variant allele of XPC, XPC-PAT+. We found that the frequency of the XPC-PAT+ allele was higher in the cases (0.409) than in the controls (0.333; P = 0.007). Fifty cases (17.4%) and 37 controls (11.9%) were XPC-PAT+/+, and 135 (47.0%) cases and 133 controls (42.8%) were XPC-PAT+/-. XPC-PAT+/- and XPC-PAT+/+ subjects were at significantly increased risk for SCCHN [adjusted odds ratios = 1.44 and 1.85, respectively (95% confidence intervals, 1.01-2.05 and 1.12-3.05, respectively; trend test, P = 0.007)]. We did not find ethnic difference in the frequency of XPC-PAT+ allele among four groups aged between 19 and 75 years: non-Hispanic whites, 294; African-Americans, 178; Hispanic-Americans, 103; and native Chinese, 119 (0.333, 0.281, 0.296, and 0.353, respectively). The case-control findings support the hypothesis that the XPC-PAT+ allele may contribute to the risk of developing SCCHN.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309287

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  XPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.

Authors:  Chuan Liu; Qinghua Yin; Mingzhen Ying; Junhui Lin; Lian Li; Guangjun Jiao; Mei Wang; Yajie Wang
Journal:  Mol Biol Rep       Date:  2014-01-03       Impact factor: 2.316

2.  Modulation of DNA damage/DNA repair capacity by XPC polymorphisms.

Authors:  Yimin Zhu; Hushan Yang; Qin Chen; Jie Lin; H Barton Grossman; Colin P Dinney; Xifeng Wu; Jian Gu
Journal:  DNA Repair (Amst)       Date:  2007-10-17

3.  Hodgkin lymphoma risk: role of genetic polymorphisms and gene-gene interactions in DNA repair pathways.

Authors:  Claudia M Monroy; Andrea C Cortes; Mirtha Lopez; Elizabeth Rourke; Carol J Etzel; Anas Younes; Sara S Strom; Randa El-Zein
Journal:  Mol Carcinog       Date:  2011-03-03       Impact factor: 4.784

4.  XPC Lys939Gln polymorphism, smoking and risk of sporadic colorectal cancer among Malaysians.

Authors:  Abdul Aziz Ahmad Aizat; Mohd Shahpudin Siti Nurfatimah; Mustapha Mohd Aminudin; Ravindran Ankathil
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

5.  Using haplotype analysis to elucidate significant associations between genes and Hodgkin lymphoma.

Authors:  Anthony M D'Amelio; Claudia Monroy; Randa El-Zein; Carol J Etzel
Journal:  Leuk Res       Date:  2012-08-14       Impact factor: 3.156

6.  The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function.

Authors:  Sikandar G Khan; Vanessa Muniz-Medina; Tala Shahlavi; Carl C Baker; Hiroki Inui; Takahiro Ueda; Steffen Emmert; Thomas D Schneider; Kenneth H Kraemer
Journal:  Nucleic Acids Res       Date:  2002-08-15       Impact factor: 16.971

7.  CASP3 polymorphisms and risk of squamous cell carcinoma of the head and neck.

Authors:  Kexin Chen; Hui Zhao; Zhibin Hu; Li-E Wang; Wei Zhang; Erich M Sturgis; Qingyi Wei
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

8.  Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk.

Authors:  Randa El-Zein; Claudia M Monroy; Carol J Etzel; Andrea C Cortes; Yun Xing; Amanda L Collier; Sara S Strom
Journal:  Cancer       Date:  2009-04-15       Impact factor: 6.860

9.  XPC intron11 C/A polymorphism as a risk factor for prostate cancer.

Authors:  Yoshihiro Yoshino; Shouhei Takeuchi; Takahiko Katoh; Yoshiki Kuroda
Journal:  Environ Health Prev Med       Date:  2016-01-08       Impact factor: 3.674

10.  XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy.

Authors:  Ruchika Gangwar; Anil Mandhani; Rama Devi Mittal
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-19       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.